- Global Pharma News & Resources

Global Graves Disease Treatment Market­ 2020:Outlook,Trends,Share,COVID 19 Impact On Size,Key Players-ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA

A new research study from “Data Bridge Market Research”  with title Graves disease treatment Insights 2019, Global  Analysis and Forecast to 2026 provides an in-depth assessment of the Graves disease treatment including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. Some of the leading key players profiled in this study: Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA, Amgen Inc, , Horizon Therapeutics plc, Medtronic, Immunovant, Inc, among others.

Global Graves disease treatment market­ is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Graves disease treatment market ­for Global Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @

Global Graves disease treatment market­ is expected to grow at a steady CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rise in number of patients with thyroid disorders, favorable reimbursement policies for treatment and increase in awareness about the complications associated with thyroid disorders and rising investment in the research & development of treatments for Hashimoto’s thyroiditis is expected to drive the market.

Key Developments in the Market

  • In June 2019, Horizon Therapeutics plc is developing teprotumumab, a complex protein that works by inhibiting the insulin-like growth factor I receptor (IGF-1R) for the treatment of Graves disease, currently ongoing in phase lll of OPTIC l trial. With this development the company provides better solution for the treatment of graves disease
  • In June 2019, Apitope is developing a novel drug ATX-GD-59, a peptide mixture of two different, highly soluble apitopes derived from TSH-receptor for the treatment of Graves disease currently ongoing in phase l clinical trial. If approved it will become the first innovative treatment in more than 60 years and will provide potential treatment to target the immunological basis of Graves’ disease

Buy this Report (Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries) @

Segmentation: Global Graves Disease Treatment Market­

By Mechanism of Action Type

  • Anti-thyroid Agents
  • Beta Blockers
  • Corticosteroids
  • Others

By Drugs

  • Propylthiouracil
  • Methimazole
  • Propranolol
  • Prednisone
  • Others

By Diagnosis

  • Physical Exam
  • Blood Test
  • Radioactive Iodine Uptake Test
  • Ultrasound
  • Imaging Tests
  • By Treatment
  • Medication
  • Radioactive Iodine Therapy
  • Surgery
  • Others

By Route of Administration

  • Oral
  • Intravenous
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

For More Insights Get FREE Detailed TOC @

Market Drivers

  • High prevalence of autoimmune diseases such as Grave’s disease and Hashimoto’s thyroiditis is driving the market growth
  • Various national health programs related to thyroid disease that raise awareness regarding such diseases further boosts the growth of this market
  • Favorable reimbursement policies for the treatment
  • Increasing iodine disorder and thyroid tumors screening is also fueling the market growth

Market Restraints

  • High costs associated with the treatment and the usage of alternative medicines for the treatment of thyroid disorders is hindering the market growth
  • Side-effects associated with the current medication also restricts the market growth
  • Stringent government regulations is hampering the market growth

Key questions answered in Graves disease treatment Report:

  • What will the Graves disease treatment market size and the growth rate be in 2026?
  • What are the latest market trends impacting the growth of the Graves disease treatment market?
  • Who are the global topmost manufacturers of Graves disease treatment industry: Company Outline, Product Specification and Major Types Analysis, Market Performance, Sales Market, Contact Information?
  • What are the types and applications of Graves disease treatment? What is the market share of each type and application?
  • What are the upstream raw materials and manufacturing equipment of Graves disease treatment? Up Stream Industries Analysis, Raw Material and Suppliers, Equipment and Suppliers, Manufacturing Analysis, Manufacturing Process, Manufacturing Cost Structure, Manufacturing Plants Distribution Analysis, Industry Chain Structure Analysis
  • What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Graves disease treatment?
  • What are the Graves disease treatment market opportunities and threats faced by the vendors in the global Graves disease treatment Industry?

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 03-Nov-2020